NZ523103A - Salt adjuvant-containing vaccine freeze-dried compositions in a powder form for transdermal delivery from a needless syringe - Google Patents

Salt adjuvant-containing vaccine freeze-dried compositions in a powder form for transdermal delivery from a needless syringe

Info

Publication number
NZ523103A
NZ523103A NZ523103A NZ52310301A NZ523103A NZ 523103 A NZ523103 A NZ 523103A NZ 523103 A NZ523103 A NZ 523103A NZ 52310301 A NZ52310301 A NZ 52310301A NZ 523103 A NZ523103 A NZ 523103A
Authority
NZ
New Zealand
Prior art keywords
weight
powder
salt
freeze
adjuvant
Prior art date
Application number
NZ523103A
Other languages
English (en)
Inventor
Yuh-Fun Maa
Lu Zhao
Steven Joseph Prestrelski
Original Assignee
Powderject Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Vaccines Inc filed Critical Powderject Vaccines Inc
Publication of NZ523103A publication Critical patent/NZ523103A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
NZ523103A 2000-06-08 2001-06-08 Salt adjuvant-containing vaccine freeze-dried compositions in a powder form for transdermal delivery from a needless syringe NZ523103A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21058100P 2000-06-08 2000-06-08
US59077700A 2000-06-08 2000-06-08
PCT/US2001/018494 WO2001093829A2 (en) 2000-06-08 2001-06-08 Powder compositions

Publications (1)

Publication Number Publication Date
NZ523103A true NZ523103A (en) 2005-08-26

Family

ID=26905296

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ523103A NZ523103A (en) 2000-06-08 2001-06-08 Salt adjuvant-containing vaccine freeze-dried compositions in a powder form for transdermal delivery from a needless syringe
NZ552576A NZ552576A (en) 2000-06-08 2001-06-08 Salt adjuvant-containing gel-forming free flowing compositions in a powder form for transdermal delivery from a needless syringe

Family Applications After (1)

Application Number Title Priority Date Filing Date
NZ552576A NZ552576A (en) 2000-06-08 2001-06-08 Salt adjuvant-containing gel-forming free flowing compositions in a powder form for transdermal delivery from a needless syringe

Country Status (11)

Country Link
EP (1) EP1289494A2 (ko)
JP (1) JP2003535119A (ko)
KR (1) KR20030020294A (ko)
CN (1) CN1438874A (ko)
AU (1) AU2001275371B9 (ko)
BR (1) BR0111494A (ko)
CA (1) CA2412197A1 (ko)
IL (1) IL153241A0 (ko)
MX (1) MXPA02012039A (ko)
NZ (2) NZ523103A (ko)
WO (1) WO2001093829A2 (ko)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002101412A2 (en) * 2001-06-08 2002-12-19 Powderject Vaccines, Inc. Spray freeze-dried compositions
AU2002366267B2 (en) * 2001-11-19 2007-05-10 Becton, Dickinson And Company Pharmaceutical compositions in particulate form
WO2003087339A2 (en) * 2002-04-11 2003-10-23 Medimmune Vaccines, Inc. Spray freeze dry of compositions for pulmonary administration
DE10339197A1 (de) * 2003-08-22 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Sprühgetrocknete amorphe Pulver mit geringer Restfeuchte und guter Lagerstabilität
MX2007003726A (es) * 2004-09-28 2007-06-15 Johnson & Johnson Estabilizaci??n de agentes inmunologicamente activos con adyuvantes de alumbre.
CN101242948B (zh) * 2005-06-27 2012-06-13 应用薄膜股份有限公司 基于磷酸铝的微球
AU2006299310A1 (en) 2005-10-04 2007-04-12 Alk-Abello A/S Solid vaccine formulation
US20090035326A1 (en) * 2005-11-01 2009-02-05 Novartis Ag Compositions with antigens adsorbed to calcium phosphate
US20080226729A1 (en) * 2006-09-08 2008-09-18 Becton, Dickinson And Company Stable powder formulations of alum-adsorbed vaccines
CA2702340C (en) 2006-10-12 2014-12-16 The University Of Queensland Compositions and methods for modulating immune responses
EP2131857B1 (en) * 2007-03-22 2015-07-29 The Regents of the University of Colorado, a body corporate Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
WO2009012601A1 (en) * 2007-07-26 2009-01-29 Sanofi Pasteur Limited Antigen-adjuvant compositions and methods
BRPI0909820A2 (pt) * 2008-03-05 2015-08-11 Sanofi Pasteur Processo para estabilização de composição de vacina contra gripe, para estabilização de composição de vacina contendo adjuvante e para preparação de vacina, composições de vacina, kit de vacina e método de estocagem de uma matéria prima
WO2010038076A1 (en) 2008-10-02 2010-04-08 Pharmathene Uk Limited Anthrax vaccine formulation and uses thereof
AU2011234264B2 (en) 2010-03-31 2016-02-04 Stabilitech Ltd Excipients for stabilising viral particles, polypeptides or biological material
ES2708989T3 (es) 2010-03-31 2019-04-12 Stabilitech Biopharma Ltd Método de conservación de adyuvantes de alumbre y vacunas potenciadas con alumbre
DK2898890T3 (da) 2010-03-31 2019-11-25 Stabilitech Biopharma Ltd Stabilisering af viruspartikler
WO2012058715A1 (en) 2010-11-01 2012-05-10 University Of Technology, Sydney Immune-modulating agents and uses therefor
EA201390810A1 (ru) 2010-12-02 2013-09-30 Онколитикс Байотек Инк. Жидкие вирусные составы
CN103269716B (zh) 2010-12-02 2015-05-27 昂科利蒂克斯生物科技公司 冻干病毒制剂
CN102133396B (zh) * 2011-03-16 2013-10-16 中国人民解放军第三〇二医院 一种疫苗注射剂及其制备方法
GB201117233D0 (en) 2011-10-05 2011-11-16 Stabilitech Ltd Stabilisation of polypeptides
IN2014MN01714A (ko) * 2012-03-05 2015-05-29 Staat Der Nederlanden Vert Door De Minister Van Vwsministerie Van Volksgezondheid Welzijn En Sport D
KR101441539B1 (ko) * 2013-04-01 2014-09-18 재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 흡습성이 개선된 접착제 조성물 및 이의 제조방법
CN103641886B (zh) * 2013-11-26 2015-07-29 精晶药业股份有限公司 一种丙谷二肽的精制方法
GB201406569D0 (en) 2014-04-11 2014-05-28 Stabilitech Ltd Vaccine compositions
GB2562241B (en) 2017-05-08 2022-04-06 Stabilitech Biopharma Ltd Vaccine compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2505657A1 (fr) * 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
JPS6013718A (ja) * 1983-07-05 1985-01-24 Chemo Sero Therapeut Res Inst Ｂ型肝炎ワクチン
JP2749449B2 (ja) * 1992-12-28 1998-05-13 ユー、シイ−チャン 不揮発性半導体メモリセル
DE69332031T2 (de) * 1993-01-08 2002-12-19 Csl Ltd Impfstoffpräparate
TW360548B (en) * 1993-04-08 1999-06-11 Powderject Res Ltd Products for therapeutic use
US5902565A (en) * 1993-12-24 1999-05-11 Csl Limited Spray dried vaccine preparation comprising aluminium adsorbed immunogens
RU2096042C1 (ru) * 1996-11-06 1997-11-20 Виктор Иванович Ситьков Способ получения поливалентной вакцины против лептоспироза животных
AU756828B2 (en) * 1997-12-02 2003-01-23 Powderject Vaccines, Inc. Transdermal delivery of particulate vaccine compositions

Also Published As

Publication number Publication date
AU7537101A (en) 2001-12-17
EP1289494A2 (en) 2003-03-12
JP2003535119A (ja) 2003-11-25
KR20030020294A (ko) 2003-03-08
CN1438874A (zh) 2003-08-27
AU2001275371B2 (en) 2006-12-21
MXPA02012039A (es) 2003-06-06
WO2001093829A3 (en) 2002-06-13
BR0111494A (pt) 2004-01-13
WO2001093829A2 (en) 2001-12-13
AU2001275371B9 (en) 2007-06-07
IL153241A0 (en) 2003-07-06
NZ552576A (en) 2008-06-30
CA2412197A1 (en) 2001-12-13

Similar Documents

Publication Publication Date Title
US20050266021A1 (en) Powder compositions
AU2001275371B9 (en) Powder compositions
US7229645B2 (en) Spray freeze-dried compositions
EP1146861B1 (en) Hydrogel particle formulations
AU756828B2 (en) Transdermal delivery of particulate vaccine compositions
Schiffter et al. Spray-freeze-drying of nanosuspensions: the manufacture of insulin particles for needle-free ballistic powder delivery
CA2467833A1 (en) Pharmaceutical compositions in particulate form
US20100173005A1 (en) Microparticle formulations for sustained-release of bioactive compounds
US20050191361A1 (en) Hydrogel particle formation
EP1592443B1 (en) Improved anthrax vaccines and delivery methods
US20020051821A1 (en) Aliginate particle formulation
AU770235B2 (en) Delivery of microparticle formulations using needleless syringe device for sustained-release of bioactive compounds
US20040213798A1 (en) Spray-dried alum compositions
AU2001275371A1 (en) Powder compositions
Ziegler Needle-free delivery of powdered protein vaccines: a new and rapidly developing technique

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed
RENW Renewal (renewal fees accepted)